Fluticasone, Vilanterol

Revinty Ellipta 92 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)

92 µg + 22 µg polvo para inhalación (unidosis)SpainMarketedAuthorised 28 Aug 2025

In other countries

The same active substances on other registers, the same brand first.

Revinty ElliptaEuropean Union · GlaxoSmithKline Trading Services LimitedSame brand
Breo ElliptaNew Zealand · Powder for inhalation 100 mcg with vilanterol 25 mcgSame form
Relvar® Ellipta®Serbia · 22mcg+92mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame form
Relvar® Ellipta®Serbia · 22mcg+184mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame form
Relvar® Ellipta®Serbia · 22mcg+184mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame form
RELVAR ELLIPTA 200/25 mcg inhalation powderSaudi Arabia · Glaxo OperationSame form
Breo ElliptaCanada · 200 MCG / ACT + 25 MCG / ACT · Powder · Glaxosmithkline INC

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Fluticasone, Vilanterol

Revinty Ellipta 92 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)

92 µg + 22 µg polvo para inhalación (unidosis)SpainMarketedAuthorised 28 Aug 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Breo ElliptaCanada · 100 MCG / ACT + 25 MCG / ACT · Powder · Glaxosmithkline INC

Relvar ElliptaEuropean Union · GlaxoSmithKline Trading Services Limited

Relvar ElliptaSaudi Arabia · Glaxo Operation

Packs

Pack	Code	Status
REVINTY ELLIPTA 92 MICROGRAMOS/22 MICROGRAMOS POLVO PARA INHALACION (UNIDOSIS), 1 inhalador de 30 dosis	768316

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Fluticasone, Vilanterol
Strength: 92 µg + 22 µg
Dosage form: polvo para inhalación (unidosis)
Route: vía inhalatoria
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 28 Aug 2025
Registration: 114929002IP
Marketing authorisation holder: Glaxosmithkline Trading Services Limited
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica

Fluticasone + Vilanterol · 92 µg + 22 µg · polvo para inhalación (unidosis)

Spain

Revinty Ellipta 92 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)Fluticasone + Vilanterol · 92 µg + 22 µg · polvo para inhalación (unidosis)Spain